Related Experiment Video
Updated: May 3, 2026

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
Published on: June 11, 2014
[Invasive breast cancer: the current WHO classification]
A Lebeau1, M Kriegsmann, E Burandt
1Institut für Pathologie, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland, a.lebeau@uke.de.
The 2012 World Health Organization (WHO) breast tumor classification provides updated standards for breast cancer diagnosis. This guide details invasive carcinomas, incorporating molecular data and prognostic features for better patient care.
Area of Science:
- Pathology
- Oncology
- Genetics
Context:
- The World Health Organization (WHO) classification of breast tumors establishes international standards for tumor categorization and nomenclature.
- The 2012 fourth edition represents a significant update, incorporating current knowledge on classification, immunohistology, differential diagnosis, and genetics of breast lesions.
Purpose:
- To provide an updated overview of the 2012 WHO classification of breast tumors, focusing on invasive carcinomas.
- To detail the modifications from the previous edition, including revised terminology, reclassified entities, and new molecular data.
- To supplement histological diagnostic definitions with clinical, macroscopic, molecular, prognostic, and predictive features.
Summary:
- The 2012 WHO classification of breast tumors updates tumor categorization and nomenclature standards.
- This article specifically addresses invasive carcinomas, integrating clinical, macroscopic, and molecular characteristics.
- Key updates include modified terms, reclassified entities, and the incorporation of current molecular data and prognostic/predictive features.
Impact:
- Facilitates standardized and accurate diagnosis of breast tumors globally.
- Enhances understanding of invasive breast carcinomas by integrating diverse diagnostic parameters.
- Supports improved patient management through comprehensive prognostic and predictive information.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025